The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Chip Parkinson, CEO, GiftHealth, explains how AI, real-time data, and closer payer collaboration are driving the next phase ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.